Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer

By sjmartinez • April 30, 2024

Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May;13(9):e7212. doi: 10.1002/cam4.7212. PMID: 38686626; PMCID: PMC11058674.

Tags: APG‐157, Digestive Diseases, Head and neck cancer, Hematology/Oncology, immune checkpoint inhibitors, microbiome, Publications, tumor microenvironment, Veterans Administration

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across Racial and Ethnic Groups

Patel C, Abboud Y, Karkra R, Qureshi I, Gaglio P, Lingiah V, Al-Khazraji A, Hajifathalian K. Trends in Early-Onset Colorectal Adenocarcinoma and Neuroendocrine Tumors Across[...]

Reducing demographic bias in biomedical machine learning for cancer detection using cfDNA methylation

Li S, Zeng W, Li W, Liu CC, Zhou Y, Ni X, Stackpole ML, Yeh AH, Melehy A, Lu DS, Raman SS, Hsu W, Mishra[...]